Prevention of postmenopausal bone loss by rectal calcitonin
β Scribed by J. -Y. Reginster; I. Jupsin; R. Deroisy; I. Biquet; N. Franchimont; P. Franchimont
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 400 KB
- Volume
- 56
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Biochemical parameters reflecting bone resorption [urinary calcium/creatinine (Ca/Cr) and hydroxyproline/creatinine (OH/Cr)] were related to serum estrogens [estrone (E1) and estradiol (E2)] in 262 healthy women including 158 patients receiving estrogen replacement therapy (ERT) for at least 6 month
In order to devise a convenient and effective therapeutic regimen of intranasal salmon calcitonin (sCT) for the treatment of early postmenopausal bone loss, we studied the effects of a 1-year course of sCT nasal spray on vertebral mineral content (VMC), assessed by dual photon densitometry, and bone